http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111388494-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111388494-B |
| titleOfInvention | Application of astilbin in preparation of medicine for treating pancreatitis |
| abstract | The invention discloses an application of astilbin in the preparation of a drug for treating and preventing severe acute pancreatitis, and also discloses a drug for treating pancreatitis, the drug includes astilbin, and pharmaceutically acceptable Adjuvant, wherein the astilbin is the only active ingredient. The medicine with astilbin as the only active ingredient provided by the invention has no obvious toxic and side effects, and has higher safety in treating pancreatitis. |
| priorityDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.